TOP TIERMARKET NEWSWIRE
SEC Form 4 history

INMED PHARMACEUTICAL (INM) insider trades

INMED PHARMACEUTICAL (INM) insider trading activity (SEC Form 4). Over the trailing 90 days, INM insiders filed 6 purchases totalling $204K and 0 sales totalling $0 — net BUYING of $204K. Most recent filing: Oct 27, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
6
$204K
Sells (90d)
0
$0
Net (90d)
+$204K
net buying
Most recent
Oct 27, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Oct 27, 2026Adar1 Capital Management, LLC10%P Purchase—$1.32$5filing
Oct 20, 2026Adar1 Capital Management, LLC10%P Purchase—$1.32$1Kfiling
Oct 15, 2026Adar1 Capital Management, LLC10%P Purchase—$1.33$13Kfiling
Oct 8, 2026Adar1 Capital Management, LLC10%P Purchase—$1.33$14Kfiling
Oct 5, 2026Adar1 Capital Management, LLC10%P Purchase—$1.33$57Kfiling
Sep 16, 2026Adar1 Capital Management, LLC10%P Purchase—$1.30$118Kfiling
Jul 17, 2026Adar1 Capital Management, LLC10%P Purchase—$1.56$2Kfiling
Jul 16, 2026Vivo Opportunity, LLC10%P Purchase—$1.55$32Kfiling
Jul 2, 2026Vivo Opportunity, LLC10%P Purchase—$1.55$10Kfiling
Jun 10, 2026Vivo Opportunity, LLC10%P Purchase—$1.57$392Kfiling
May 21, 2026Adar1 Capital Management, LLC10%P Purchase—$1.54$722Kfiling